[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$30share](/topic/$30share) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$open @CanadaKaz is smarter than you He wouldnt have taken this job with no pay until $30/share if he didnt believe it would seriously paid off. Its not like he was leaving a bad gig at $shop Im all on @rabois" [X Link](https://x.com/Nichola68773113/status/1979510303831290126) [@Nichola68773113](/creator/x/Nichola68773113) 2025-10-18T11:30Z XXX followers, XXX engagements "Clear Street set a $30/share target for $CLSK by applying a 5x EV/EBITDA multiple to their 2027 EBITDA forecast reflecting BTC at $118K. While the multiple is unchanged converting current digital assets to cash positively impacts enterprise value and overall valuation" [X Link](https://x.com/FinancialErnie/status/1978850850224164981) [@FinancialErnie](/creator/x/FinancialErnie) 2025-10-16T15:49Z 3543 followers, 2688 engagements "Buyout in progress - $XX per share sounds about right Don't be late to the party on buyout of $WBD by $PSKY $IREN $RGTI $OKLO $BAC $QUBT $QBTS $IONQ $IREN $DVLT $WULF $TMC $OPEN $SPY $QQQ $INTC $NVDA $BBAI $TSLA $AMD $META $GOOG $AAPL $AMZN $SHOP $DIS $BYND $COOT $GNPX $DFLI" [X Link](https://x.com/KanwalBains_/status/1978835342816878974) [@KanwalBains_](/creator/x/KanwalBains_) 2025-10-16T14:48Z X followers, XXX engagements "$LXEO GUGG LXEO BUY rating $30/share PT based on compelling attributes. LXEO is leveraging cardiotropic AAVrh10 to target myocardial disease in FA and PKP2-ACM which together represent a $11Bn-$13Bn TAM in the US by estimates. Importantly: (1) dose and ISR selection benchmarked by an encouraging complement profile positions its assets to navigate the TI; (2) LX2006 RMAT and BTD for FA-CM" [X Link](https://x.com/semodough/status/1978635370993537227) [@semodough](/creator/x/semodough) 2025-10-16T01:33Z 41.5K followers, 4235 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$open @CanadaKaz is smarter than you He wouldnt have taken this job with no pay until $30/share if he didnt believe it would seriously paid off. Its not like he was leaving a bad gig at $shop Im all on @rabois"
X Link @Nichola68773113 2025-10-18T11:30Z XXX followers, XXX engagements
"Clear Street set a $30/share target for $CLSK by applying a 5x EV/EBITDA multiple to their 2027 EBITDA forecast reflecting BTC at $118K. While the multiple is unchanged converting current digital assets to cash positively impacts enterprise value and overall valuation"
X Link @FinancialErnie 2025-10-16T15:49Z 3543 followers, 2688 engagements
"Buyout in progress - $XX per share sounds about right Don't be late to the party on buyout of $WBD by $PSKY $IREN $RGTI $OKLO $BAC $QUBT $QBTS $IONQ $IREN $DVLT $WULF $TMC $OPEN $SPY $QQQ $INTC $NVDA $BBAI $TSLA $AMD $META $GOOG $AAPL $AMZN $SHOP $DIS $BYND $COOT $GNPX $DFLI"
X Link @KanwalBains_ 2025-10-16T14:48Z X followers, XXX engagements
"$LXEO GUGG LXEO BUY rating $30/share PT based on compelling attributes. LXEO is leveraging cardiotropic AAVrh10 to target myocardial disease in FA and PKP2-ACM which together represent a $11Bn-$13Bn TAM in the US by estimates. Importantly: (1) dose and ISR selection benchmarked by an encouraging complement profile positions its assets to navigate the TI; (2) LX2006 RMAT and BTD for FA-CM"
X Link @semodough 2025-10-16T01:33Z 41.5K followers, 4235 engagements
/topic/$30share/posts